Combination treatment of human pancreatic cancer xenograft models with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib and oncolytic herpes simplex virus HF10.
Yamamura K, Kasuya H, Sahin TT, Tan G, Hotta Y, Tsurumaru N, Fukuda S, Kanda M, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Fujii T, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Tanaka M, Kodera Y.
Yamamura K, et al. Among authors: fujiwara m.
Ann Surg Oncol. 2014 Feb;21(2):691-8. doi: 10.1245/s10434-013-3329-3. Epub 2013 Oct 30.
Ann Surg Oncol. 2014.
PMID: 24170435